CDK9-IN-23

• Description :

  CDK9-IN-23 (Example 4) is a CDK9 inhibitor with an IC50 of [1].

• CAS Number :

  [2761572-96-5]

• UNSPSC :

  12352005

• Target :

  CDK

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/cdk9-in-23.html

• Solubility :

  10 mM in DMSO

• Smiles :

  ClC1=C(C=C(N=C1)NC([C@@H]2C[C@@H](CCC2)NC(C)=O)=O)C3=C4C(NCCO4)=CC=C3

• Molecular Formula :

  C22H25ClN4O3

• Molecular Weight :

  428.91

• References & Citations :

  [1]Liang Lu, et al. Heterocycle cdk inhibitors and their use thereof. Patent WO2022035799A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  CDK9